AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.800

+0.0303.90%

Volume:3.54M

Turnover:2.79M

Market Cap:381.64M

PE:-47.06

High:0.800

Open:0.780

Low:0.775

Close:0.770

52wk High:0.830

52wk Low:0.180

Shares:477.05M

Float Shares:347.84M

Volume Ratio:1.40

T/O Rate:1.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.020

ROE:-45.55%

ROA:-21.00%

PB:27.70

PE(LYR):-40.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

50

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.8,"timestamp":1789711920000,"preClose":0.77,"halted":0,"volume":3537042,"delay":0,"changeRate":0.038961038961038995,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":477054949,"eps":-0.017,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"09-18 16:12:00 AEST","open":0.78,"high":0.8,"low":0.775,"amount":2794751,"amplitude":0.032468,"askPrice":0.8,"askSize":39544,"bidPrice":0.79,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.017,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789948800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.77,"openAndCloseTimeList":[[1789689600000,1789711200000]],"volumeRatio":1.4026998299599738,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SPL.AU","preClose":0.77,"auctionPrice":0.8,"auctionVolume":200628,"auction":3,"marketStatus":"盘后竞价","timestamp":1789711818666}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-21.00%","roe":"-45.55%","lyrEps":-0.02,"volumeRatio":1.4026998299599738,"shares":477054949,"dividePrice":0,"high":0.8,"amplitude":0.032468,"preClose":0.77,"low":0.775,"week52Low":0.18,"pbRate":"27.70","psRate":"30.13","week52High":0.83,"institutionHeld":0,"latestPrice":0.8,"committee":-0.775503,"eps":-0.017,"divideRate":0,"volume":3537042,"delay":0,"ttmEps":-0.017,"open":0.78,"prevYearClose":0.351,"prevWeekClose":0.8,"prevMonthClose":0.72,"prevQuarterClose":0.682,"fiveDayClose":0.705,"twentyDayClose":0.73,"sixtyDayClose":0.677},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-17","symbol":"SPL.AU","defaultRemindTime":1784246400000,"type":"split","dateTimestamp":1784210400000,"forFactor":974214,"toFactor":1000000,"ratio":0.974214}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":50,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":0.1348},{"period":"1month","weight":0.1034},{"period":"3month","weight":0.1817},{"period":"6month","weight":0.7467},{"period":"1year","weight":5.5574},{"period":"ytd","weight":1.2792}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":-0.0098},{"period":"3month","weight":0.0481},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.1055},{"period":"ytd","weight":0.0411}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.019366},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.019367},{"month":3,"riseRate":0.384615,"avgChangeRate":0.02555},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.017937},{"month":5,"riseRate":0.346154,"avgChangeRate":-0.039405},{"month":6,"riseRate":0.576923,"avgChangeRate":0.041309},{"month":7,"riseRate":0.423077,"avgChangeRate":0.002565},{"month":8,"riseRate":0.692308,"avgChangeRate":0.099703},{"month":9,"riseRate":0.5,"avgChangeRate":0.017785},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016562},{"month":11,"riseRate":0.5,"avgChangeRate":0.028116},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.006043}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}